Advertisement
CELC vs IMVT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and IMVT is a Hold.
CELC's RSI Indicator climbs out of oversold territory
The RSI Oscillator for CELC moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In 21 of the 23 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +6.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where CELC advanced for three days, in 248 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
CELC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CELC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for CELC entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CELC's P/B Ratio (-229.709) is very low in comparison to the industry average of (3.009). P/E Ratio (-13.953) is within average values for comparable stocks, (-1.027). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.622) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. CELC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CELC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
IMVT's Indicator enters downward trend
The Aroon Indicator for IMVT entered a downward trend on October 20, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 224 similar instances where the Aroon Indicator formed such a pattern. In 196 of the 224 cases the stock moved lower. This puts the odds of a downward move at 88%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IMVT's RSI Oscillator exited the oversold zone, 23 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
Following a +6.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMVT advanced for three days, in 204 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
IMVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.030) is normal, around the industry mean (3.009). P/E Ratio (-10.174) is within average values for comparable stocks, (-1.027). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.622) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 61 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. IMVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CELC | IMVT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 84 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 1 Undervalued | 36 Fair valued | |
PROFIT vs RISK RATING 1..100 | 70 | 61 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 65 | 63 | |
P/E GROWTH RATING 1..100 | 15 | 17 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CELC's Valuation (1) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for IMVT (36) in the null industry. This means that CELC’s stock grew somewhat faster than IMVT’s over the last 12 months.
IMVT's Profit vs Risk Rating (61) in the null industry is in the same range as CELC (70) in the Miscellaneous Commercial Services industry. This means that IMVT’s stock grew similarly to CELC’s over the last 12 months.
IMVT's SMR Rating (98) in the null industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that IMVT’s stock grew similarly to CELC’s over the last 12 months.
IMVT's Price Growth Rating (63) in the null industry is in the same range as CELC (65) in the Miscellaneous Commercial Services industry. This means that IMVT’s stock grew similarly to CELC’s over the last 12 months.
CELC's P/E Growth Rating (15) in the Miscellaneous Commercial Services industry is in the same range as IMVT (17) in the null industry. This means that CELC’s stock grew similarly to IMVT’s over the last 12 months.
| CELC | IMVT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 79% |
| Stochastic ODDS (%) | N/A | N/A |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | N/A | N/A |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 81% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 80% |
| Advances ODDS (%) | 1 day ago 85% | 1 day ago 76% |
| Declines ODDS (%) | 7 days ago 85% | 5 days ago 81% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 84% | 1 day ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CELC’s FA Score shows that 2 FA rating(s) are green while IMVT’s FA Score has 1 green FA rating(s).
- CELC’s FA Score: 2 green, 3 red.
- IMVT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CELC’s TA Score shows that 3 TA indicator(s) are bullish while IMVT’s TA Score has 3 bullish TA indicator(s).
- CELC’s TA Score: 3 bullish, 2 bearish.
- IMVT’s TA Score: 3 bullish, 2 bearish.
Price Growth
CELC (@Biotechnology) experienced а -5.05% price change this week, while IMVT (@Biotechnology) price change was -0.42% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.45%. For the same industry, the average monthly price growth was -16.03%, and the average quarterly price growth was -14.84%.
Reported Earning Dates
CELC is expected to report earnings on Nov 11, 2026.
IMVT is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Biotechnology (-0.45% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ODTE | 24.41 | 0.08 | +0.34% |
| VegaShares SPX NDX RTY Premium Income ETF (ODTE) | |||
| HYS | 89.55 | -0.04 | -0.04% |
| PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund (HYS) | |||
| RMNY | 23.28 | -0.01 | -0.04% |
| Rockefeller New York Municipal Bond ETF (RMNY) | |||
| MARM | 34.65 | -0.03 | -0.09% |
| FT Vest U.S. Equity Max Buffer ETF - March (MARM) | |||
| QTOP | 37.48 | -0.19 | -0.50% |
| iShares Nasdaq Top 30 Stocks ETF (QTOP) | |||
IMVT and
Correlation & Price change
A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.
| Ticker / NAME | Correlation To IMVT | 1D Price Change % | ||
|---|---|---|---|---|
| IMVT | 100% | +3.51% | ||
| ROIV - IMVT | 63% Loosely correlated | +0.63% | ||
| KURA - IMVT | 54% Loosely correlated | +6.62% | ||
| NAMS - IMVT | 45% Loosely correlated | +5.03% | ||
| SYRE - IMVT | 45% Loosely correlated | +7.88% | ||
| LXEO - IMVT | 45% Loosely correlated | +9.42% | ||
More | ||||